An announced COVID vaccine policy change followed by updates to the immunization schedules leave clinicians with more ...

While COVID-19 is not at the top of the public’s mind, the CDC has said pregnant women and infants remain at high risk of ...

Chikungunya, a mosquito-borne virus, has been detected at higher-than-expected rates among U.S. travelers from the Indian state. To reduce infection risk, the CDC urges travelers to adopt mosquito ...

A study published in The Lancet Planetary Health reveals that tropical mosquito-borne diseases such as dengue and chikungunya ...

The FDA and CDC are recommending a pause on the use of Ixchiq (chikungunya vaccine, live) in patients 60 years and older during an ongoing safety investigation.

The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya ...

The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

Mosquitoes can tranmist dengue virus, which has already caused local cases in Florida in 2025... | Clinical And Molecular Dx ...

Typical symptoms of chikungunya include fever, severe joint pain, headache, muscle pain and a rash, according to the CDC. Most people recover within a week, but some may experience “severe and ...

The approval applies to anyone aged 18 and older who has a risk of being exposed to the virus. But the FDA and the Centers ...

US health officials are telling travelers aged 60 and older to avoid a chikungunya vaccine while they investigate possible side effects.